Delirium, Agitation/Sedation, Pain and Dyspnea in Respiratory Intensive Care Unit (NIVILIUM) (NIVILIUM)

May 9, 2023 updated by: Alessandro Marchioni, University of Modena and Reggio Emilia

Longitudinal Assessment of Delirium, Agitation/Sedation, Pain and Dyspnea in Patients Admitted to Respiratory Intensive Care Unit for Acute Respiratory Failure (NIVILIUM)

Non-Invasive Mechanical Ventilation (NIV) has been increasingly used in the treatment of acute respiratory failure. Notwithstanding failure rates still remains high, ranging from 5% to 60%. The onset of delirium, agitation, pain and dyspnea may contribute to reduce the success rate of non invasive ventilation treatment. The aim of this study is to assess the incidence and impact of delirium, agitation, pain and dyspnea on clinical outcomes in a population of patient admitted to Respiratory Intensive Care Unit undergoing Non-Invasive Mechanical Ventilation for Acute Respiratory Failure.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

92

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Modena, Italy
        • Recruiting
        • Azienda Ospedaliero Universitaria Policlinico di Modena
        • Contact:
          • Alessandro Marchioni

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Patients with acute respiratory failure admitted to the Respiratory Intensive Care Unit of the University Hospital of Modena undergoing non invasive mechanical ventilation not known for psychiatric disease or dementia

Description

Inclusion Criteria:

  • patients with acute respiratory failure admitted to the Respiratory Intensive Care Unit of the University Hospital of Modena undergoing non invasive mechanical ventilation

Exclusion Criteria:

  • age lower than 18
  • Glasgow Coma Scale lower than 10 within 24 hours from Respiratory Intensive Care Unit admission
  • need for immediate orotracheal intubation
  • pregnancy
  • previously established psychiatric disease or dementia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of delirium
Time Frame: 7 days from Respiratory Intensive Care Unit admission
The onset of delirium will be assessed through the Confusion Assessment Method for Intensive Care Unit 7 scale, ranges 0-7, values > 2 indicate the presence of delirium
7 days from Respiratory Intensive Care Unit admission
Incidence of agitation
Time Frame: 7 days from Respiratory Intensive Care Unit admission
The onset of delirium will be assessed through the Richmond Agitation Sedation Scale ranges +4 to -5, values > 0 indicate the presence of agitation, values < 0 indicate the presence of sedation
7 days from Respiratory Intensive Care Unit admission
Incidence of pain
Time Frame: 7 days from Respiratory Intensive Care Unit admission
The onset of delirium will be assessed through the Behavioral Pain Scale, ranges 3-12, values > 4 indicate the presence of pain
7 days from Respiratory Intensive Care Unit admission
Incidence of dyspnea
Time Frame: 7 days from Respiratory Intensive Care Unit admission
The onset of delirium will be assessed through the Borg scale, ranges 0-10, values > 0 indicate the presence of dyspnea
7 days from Respiratory Intensive Care Unit admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The impact of delirium on Non Invasive Ventilation Success
Time Frame: 30 days from Respiratory Intensive Care Unit admission
The correlation between the onset of delirium and the failure rates of Non Invasive Ventilation Treatment will be assessed
30 days from Respiratory Intensive Care Unit admission
The impact of agitation on Non Invasive Ventilation Success
Time Frame: 30 days from Respiratory Intensive Care Unit admission
The correlation between the onset of agitation and the failure rates of Non Invasive Ventilation Treatment will be assessed
30 days from Respiratory Intensive Care Unit admission
The impact of pain on Non Invasive Ventilation Success
Time Frame: 30 days from Respiratory Intensive Care Unit admission
The correlation between the onset and level of pain and the failure rates of Non Invasive Ventilation Treatment will be assessed
30 days from Respiratory Intensive Care Unit admission
The impact of dyspnea on Non Invasive Ventilation Success
Time Frame: 30 days from Respiratory Intensive Care Unit admission
The correlation between the onset and level of dyspnea and the failure rates of Non Invasive Ventilation Treatment will be assessed
30 days from Respiratory Intensive Care Unit admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2019

Primary Completion (Actual)

August 1, 2020

Study Completion (Anticipated)

January 1, 2025

Study Registration Dates

First Submitted

March 14, 2019

First Submitted That Met QC Criteria

March 14, 2019

First Posted (Actual)

March 19, 2019

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Observation

Subscribe